- Home
- WERN vs FTRE Comparison
WERN vs FTRE Comparison
Compare WERN & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WERN
- FTRE
- Stock Information
- Founded
- WERN 1956
- FTRE 1996
- Country
- WERN United States
- FTRE United States
- Employees
- WERN N/A
- FTRE N/A
- Industry
- WERN Trucking Freight/Courier Services
- FTRE Medical Specialities
- Sector
- WERN Industrials
- FTRE Health Care
- Exchange
- WERN Nasdaq
- FTRE Nasdaq
- Market Cap
- WERN 2.3B
- FTRE 1.9B
- IPO Year
- WERN N/A
- FTRE N/A
- Fundamental
- Price
- WERN $37.16
- FTRE $18.70
- Analyst Decision
- WERN Hold
- FTRE Hold
- Analyst Count
- WERN 15
- FTRE 11
- Target Price
- WERN $37.33
- FTRE $23.30
- AVG Volume (30 Days)
- WERN 655.8K
- FTRE 890.4K
- Earning Date
- WERN 02-06-2025
- FTRE 03-10-2025
- Dividend Yield
- WERN 1.51%
- FTRE N/A
- EPS Growth
- WERN N/A
- FTRE N/A
- EPS
- WERN 0.73
- FTRE N/A
- Revenue
- WERN $3,097,524,000.00
- FTRE $2,975,600,000.00
- Revenue This Year
- WERN N/A
- FTRE N/A
- Revenue Next Year
- WERN $4.03
- FTRE $1.09
- P/E Ratio
- WERN $50.66
- FTRE N/A
- Revenue Growth
- WERN N/A
- FTRE 2.80
- 52 Week Low
- WERN $33.12
- FTRE $16.53
- 52 Week High
- WERN $42.48
- FTRE $41.02
- Technical
- Relative Strength Index (RSI)
- WERN 52.02
- FTRE 48.38
- Support Level
- WERN $36.19
- FTRE $16.94
- Resistance Level
- WERN $37.51
- FTRE $18.52
- Average True Range (ATR)
- WERN 0.83
- FTRE 1.00
- MACD
- WERN 0.27
- FTRE -0.02
- Stochastic Oscillator
- WERN 89.30
- FTRE 53.01
About WERN Werner Enterprises Inc.
Werner Enterprises Inc is a transportation and logistics company. The company has two reportable segments - TTS and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.
About FTRE Fortrea Holdings Inc.
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.